Andrew Ayscough

CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells

David Krige, Lindsey Needham, Lindsay J. Bawden et al. · Cancer Research · 2008 · 116 citations · Full text

Assessing molecular scaffolds for CNS drug discovery

Joan Mayol-Llinàs, Adam Nelson, William Farnaby et al. · Drug Discovery Today · 2017 · 55 citations

Medicinal Chemistry, Drug Target, Medicine +6

Structure–activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1′ side chain

Stephen J. Davies, Andrew Ayscough, R. Paul Beckett et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 33 citations · Full text

Protein Chemistry, Biochemistry, Methylene Spacer +8

1,2,4-Triazolo-[1,5-<i>a</i>]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction

Saleh A. Ahmed, Andrew Ayscough, Greg R. Barker et al. · Journal of Medicinal Chemistry · 2017 · 33 citations · Full text

Peptide Deformylase Inhibitors, Potential for a New Class of Broad Spectrum Antibacterials

John M. Clements, Andrew Ayscough, Kenneth Keavey et al. · Current Medicinal Chemistry - Anti-Infective Agents · 2002 · 27 citations